background image

Paid Clinical Trials Connecticut

Discover 1,100 paid clinical trials in Connecticut. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

AMPK-activation by Metformin in FSGS: AMP-FSGS

Recruiting
PHASE1
PHASE2

Sponsor:

Yale University

Location:

New Haven, New York

Code:

NCT06090227

Conditions

Focal Segmental Glomerulosclerosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Metformin + Standard of Care

Placebo + Standard of Care

Von Willebrand Factor in Pregnancy (VIP) Study

Recruiting

Sponsor:

University of Washington

Location:

New Haven, Hershey, Atlanta, Nashvilleshow 7 more

Code:

NCT04146376

Conditions

Von Willebrand Diseases

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Use of a postpartum diary and additional blood draws

VWF replacement therapy with Wilate

Tranexamic acid

Use of a postpartum diary and additional blood draws.

A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting
PHASE2
PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Bristol, Farmington, Great Neck, New Yorkshow 42 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia

Recruiting

Sponsor:

University of Connecticut

Location:

Storrs

Code:

NCT06579027

Conditions

Hemiplegia

Cerebral Palsy

Children, Only

Eligibility Criteria

Sex: All

Age: 3 - 8

Healthy Volunteers: Not accepted

Interventions

SPEED Training

CRAFT Training

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

Recruiting
PHASE2

Sponsor:

Mercator MedSystems, Inc.

Location:

Darien, Stony Brook, Hyattsville, Norfolkshow 9 more

Code:

NCT04858776

Conditions

Iliofemoral; Thrombosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Perivascular dexamethasone

Perivascular sham

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Waterbury, Torrington, Meriden, New Britainshow 395 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Recruiting
PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

New Haven, Stony Brook, Nyack, Bostonshow 11 more

Code:

NCT06312176

Conditions

Breast Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab tirumotecan

Pembrolizumab

Paclitaxel

Nab-paclitaxel

Capecitabine

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Recruiting

Sponsor:

UCLA

Location:

New Haven, New York, Providence, Burnt Hillsshow 17 more

Code:

NCT05230173

Conditions

Ulcerative Colitis

Crohn Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pragmatic

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Recruiting
PHASE1
PHASE2

Sponsor:

Corbus Pharmaceuticals Inc.

Location:

New Haven, Boston, Fairfax, Huntersvilleshow 11 more

Code:

NCT06265727

Conditions

Solid Tumor, Adult

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CRB-701

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Recruiting

Sponsor:

TScan Therapeutics, Inc.

Location:

New Haven, New York, Pittsburgh, Clevelandshow 10 more

Code:

NCT05812027

Conditions

Head and Neck Cancer

Cervical Cancer

Non Small Cell Lung Cancer

Melanoma

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tumor and HLA Profiling

Popular cities in Connecticut

Connecticut stands out as a prime location for a wide variety of clinical trials, largely thanks to its robust healthcare system and renowned medical research institutions. Leading centers like Yale School of Medicine, UConn Health, and Jackson Laboratory for Genomic Medicine are at the forefront of groundbreaking studies in the state.

Combining a strong focus on innovation and precision medicine makes Connecticut an ideal destination for participants seeking advanced medical treatments and the opportunity to contribute to cutting-edge research.

Why choose Connecticut for clinical trials?

Common conditions studied in Connecticut

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Connecticut